The finding of PD-L1 expresses in EVs from human urine or plasma and its correlation with disease progression in head and neck squamous cell carcinoma (40) and melanoma (27) prompted the investigation on whether it can similarly work in lung cancer. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.